FDA approves Vertex’s acute pain treatment Journavx
The US Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults ...
FDA approves new painkiller that shows promise and challenges of opioid alternatives
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.
The American Journal of Managed Care8h
Suzetrigine: First-in-Class Non-Opiate Pain Therapy is Approved by FDA
Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...
News Medical8h
Revolutionizing diabetes care with innovative targets and therapeutic options
A thorough examination of modern drugs that target particular receptors and metabolic pathways for glucose and fat metabolism is presented. Recent research has revealed innovative targets and ...
Nature9h
US drug agency approves potent painkiller — the first non-opioid in decades
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
Ever-Growing USA on MSN14h
Arialief Reviews 2025 (Consumer Report Analysis) Is This Supplement Good For Sciatic Nerve Pain Relief?
Arialief is a comprehensive nerve health supplement that specifically targets sciatic nerve pain and claims to provide ...
Grays Harbor Daily News1d
NeuroPure Exposed: What Science Says About Its Effectiveness for Nerve Pain
Neuropathy, a debilitating condition affecting millions worldwide, can significantly impair daily life and well-being. Traditional treatments often fall short, offering temporary relief at best while ...
Many cancer patients experience nerve pain from chemo
Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.
What Really Works for Nerve Pain
Have you experienced pain or tingling in your hands or feet? Those are signs of possible neuropathy, “a general term for ...